ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 644960 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 644960; 2) Community: the network communities that were significantly associated with the response to NSC 644960; 3) Molecule: the relationships between components within communities and NSC 644960; 4) MDR: the compounds that were significantly associated with the NSC 644960.

NSC Compound Enrichment Correlation
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.011265111688021 0.63739394
NSC 681638 Camptothecin Derivative 0.011544784012433 0.66564866
NSC 693167 Null 0.011544784012433 0.58427616
NSC 709237 Camptothecin Derivative 0.011544784012433 0.54350394
NSC 721514 2-(N,N-bis(2-chloroethyl)phosphorodiamidoxy)methyl-1-methyl- 5-methoxyindole-4,7-dione 0.011544784012433 0.49933636
NSC 730269 Null 0.011544784012433 0.24664942
NSC 733882 6-(3-Azidopropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.011544784012433 0.47545976
NSC 751548 Fluka catalog #46729 0.011544784012433 0.033469357
NSC 754771 Itraconazole 0.011544784012433 0.094377122
NSC 761676 Null 0.011544784012433 0.23517356
Total:48  Current:15    [First] [Prev] [Next] [Last]